The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 63.20
Ask: 66.00
Change: -1.00 (-1.54%)
Spread: 2.80 (4.43%)
Open: 64.60
High: 66.00
Low: 64.00
Prev. Close: 65.00
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings & Holdings in Company

17 Jan 2020 12:12

RNS Number : 1994A
IDOX PLC
17 January 2020
 

Idox Plc

 

Directors' Dealings & Holdings in Company

Idox plc (LSE:IDOX, "Company" or "Idox") received notification on 15 January 2020 from Kestrel Partners LLP ("Kestrel") that on 14 January 2020 it transferred, on behalf of a discretionary client, 105,720 ordinary shares of 1p each ("Shares") in the Company from accounts managed by Kestrel to the client's broker accounts. This transfer by Kestrel was made at the request of the client and there is no change in ultimate beneficial ownership. The notification also included the matters set out below.

Mr Scott, a non-executive director of Idox, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Idox.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 33,537,916 shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest hold 12,338,642 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 45,876,558 shares in the Company, which represents 10.35% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

33,537,916

7.57%

Indirect

JIM Nominees Limited

2,351,509

0.53%

Indirect

Bank of New York Nominees Ltd

9,752,823

2.20%

Indirect

Bank of New York Nominees Ltd

234,310

0.05%

 

For further information contact:

 

Idox plc +44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson / Ben Farrow (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP ('Kestrel')

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of Idox plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

IDOX Plc

b)

 

LEI

 

 

213800Z3FE6PWVSUGE70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p Ordinary Shares

 

 

 

ISIN: GB0002998192

 

b)

 

Nature of the transaction

 

 

Transfer for a client account managed by Kestrel to client account held at separate broker. No change of beneficial ownership.

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

N/A

 

105,720 Shares

 

 

 

 

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Transfer of 105,720 shares at zero cost.

 

 

e)

 

Date of the transaction

 

2020-01-14

f)

 

Place of the transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAAFXFFFEEFA
Date   Source Headline
7th Oct 20222:42 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSAcquisition
26th Sep 20227:00 amRNSExercise of Share Options & Total Voting Rights
1st Aug 20227:00 amRNSTotal Voting Rights
15th Jul 20227:00 amRNSIdox awarded new contract for Idox Cloud
28th Jun 20227:00 amRNSIssue of Equity
15th Jun 20227:00 amRNSHalf-year Report
19th May 20227:00 amRNSFY22 H1 trading update
19th Apr 202212:36 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSGrant of Options
28th Mar 20227:13 amRNSExercise of Share Options & Total Voting Rights
23rd Mar 20229:51 amRNSExercise of Share Options & Total Voting Rights
16th Mar 202211:22 amRNSResult of AGM & Board Change
16th Mar 20227:00 amRNSAGM Trading Update
21st Feb 20227:01 amRNSPosting of Annual Report and Notice of AGM
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20211:08 pmRNSForm 8.3 Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.